期刊文献+

2010年至2012年临床标本中非发酵菌的分离情况及耐药分析 被引量:4

Non-fermenter isolation and drug resistance analysis of clinical specimens from the year of 2010 to 2012
原文传递
导出
摘要 目的 探讨近3年新乡医学院第一附属医院非发酵菌分离率和非发酵菌对常用10余种抗生素的耐药性,为临床合理用药以及防止非发酵菌进一步成为致病菌提供依据.方法 用WHONET 5.5软件,对新乡医学院第一附属医院近3年不同非发酵菌的分离率在前9位(铜绿假单胞菌、鲍曼不动杆菌、嗜麦芽假单胞菌、洛非不动杆菌、斯氏假单胞菌、无色杆菌、短稳杆菌、洋葱博克霍尔德菌、脑膜败血伊丽莎白金菌)菌株的耐药情况和分离率进行分析.结果 2010年至2012年非发酵菌在临床上分离出致病菌当中所占的比例连年上升,从18.2%到27.2%直至31.2%;分离出多重高耐药率的鲍曼不动杆菌占非发酵菌的比例从7.1%到18.5%直至28.7%;分离出的其他多重高耐药率的非发酵菌如木糖氧化无色杆菌和嗜麦芽假单胞菌在非发酵菌中的比例和/或排位也逐年上升,特别是嗜麦芽假单胞菌分离率已排在非发酵菌的第3位,并且对绝大多数常用的抗生素多重耐药;低耐药率的非发酵菌分离率连续下降;耐药性方面,鲍曼不动杆菌的耐药性已全面超过铜绿假单胞菌,并且鲍曼不动杆菌对临床上经常使用的10余种抗生素耐药率绝大部分在50.0%以上;无色杆菌和嗜麦芽假单胞以及短稳杆菌对临床上经常使用的10余种抗生素耐药率绝大部分在50.0%以上,特别是嗜麦芽假单胞菌对临床上经常使用的10余种抗生素的耐药率绝大部分在90.0%以上.结论 非发酵菌在临床致病菌当中的分离率越来越高,耐药性也越来越严重,应控制和预防这种趋势的蔓延,防止更严重的后果出现. Objective To study the non-fermenter isolation rate and its drug resistance to more than 10 kinds of antibiotics at the First Affiliated Hospital to Xinxiang Medical University from the year of 2010 to 2012 in order to offer evidences for reasonable use of drugs by doctors and to prevent nonfermenters from becoming common pathogenic bacteria.Methods The infection and drug resistance of different Nonfermenters (Pseudomonas aeruginosa,Acinetobacter baumannii,Pseudomon as mahophilia,Los non Acinetobacter,Pseudomonas stutzeri,Achromobacter,Bacillus steady short,onions Bock cepacia,meningitis septicemia Elizabeth Kim bacteria)during present 3 years were analyzed by using WHONET 5.5 software.Results The infection rate from non-fermenters as pathogenic bacteria was gradually increased,with the rate from 18.2% to 27.2%,until 31.2% ; Acinetobacter Baumannii were isolated as higher infection rate and multiple drug resistance (7.1% to 18.5% until 28.7%) in pathogenic bacteria; the infection rate of other non-fermenter with infection rate of high and multiple drug resistance in pathogenic bacteria were gradually increased,such as infection rate or the precedence of Achromobacter xylosoxidans and Pseudomonas maltophilia,especially the precedence of Pseudomonas maltophilia ranged the third in non-fermenters,and Pseudomonas maltophiliai had a higher and multiple drug resistance to many antibiotics; infection rate of non-fermenters with low drug resistance gradually decreased,such as Pseudomonas fluorescens; the drug resistance rate of Acinetobacter Baumannii was higher than that of Pseudomonas aeruginosa and its drug resistance rate was over 50% to common antibiotics used clinically,as well as Pseudomonas maltophiliai and Empedobacter brevis,especially the resistance rate of Pseudomonas maltophiliai to many commonly used antibiotics was more than 90.0%.Conclusions Non-fermenter isolation rate is becoming higher clinically and its drug resistance becomes more severe,so the sanitation administration department should pay more attention to the use of antibiotics in order to prevent and control drug resistance and higher infection rate caused by non-fermenters as a serious consequence.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2014年第4期295-298,共4页 Chinese Journal of Applied Clinical Pediatrics
关键词 非发酵菌 耐药率 分离率 抗生素 Non-fermenter Drug resistance Infection frequence Antibiotics
  • 相关文献

参考文献14

  • 1付燕霞,李连新.滥用抗生素的危害及应用措施[J].中国医药导刊,2011,13(5):866-867. 被引量:15
  • 2李莉,张艳秋,郑伟超,武静茹,罗时旋,陈伟秋,李桂秋.重症监护病房常见非发酵菌分布及耐药性分析[J].微生物学杂志,2011,31(1):99-101. 被引量:2
  • 3范文,黄娥,雷鸿斌,段六生.医院不发酵糖革兰阴性杆菌的耐药性调查[J].中华医院感染学杂志,2010,20(9):1325-1326. 被引量:2
  • 4李韶今,乐永宏.非发酵菌耐药规律探讨[J].赣南医学院学报,2010,30(2):208-209. 被引量:2
  • 5孙莉军,郑晖.临床常见不发酵糖革兰阴性杆菌的耐药性探讨[J].中华医院感染学杂志,2010,20(15):2294-2295. 被引量:22
  • 6Lambiase A,Catania MR,Del Pezzo M. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients[J].European Journal of Clinical Microbiology and Infectious Diseases,2011,(08):973-980.
  • 7Hansen CR,Pressler T,Nielsen KG. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients[J].Journal of Cystic Fibrosis,2010,(01):51-58.
  • 8Raso T,Bianco O,Grosso B. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients[J].Acta Pathologica, Microbiologica et Immunologica Scandinavica,2008,(09):837-841.
  • 9Atalay S,Ece G,Samlioglu P. Clinical and microbiological evaluation of eight patients with isolated Achromobacter xylosoxidans[J].SCANDINAVIAN Journal OF INFECTIOUS DISEASES,2012,(10):798-801.
  • 10Yamamoto M,Nagao M,Hotta G. Molecular characterization of IMP-type metallo--lactamases among multidrug-resistant Achromobacter xylosoxidans[J].Journal of Antimicrobial Chemotherapy,2012,(09):2110-2113.

二级参考文献57

共引文献47

同被引文献38

  • 1Pereira V, Dias C, Vasconcelos MC, et al. Antibacterial activity and synergistic effects between Eucalyptus globulus leaf residues (essen- tial oils and extracts) and antibiotics against several isolates of respi- ratory tract infections (Pseudomonas aeruginosa) [J]. Industrial Crops and Products, 2014, 8(52): 1-7.
  • 2Campos-Garcia J, Diaz-Perez C, Diaz-Perez AL. Residues Ash214, Gln211, Glu219 and Gln221 contained in the subfamily 3 catalytic signature of the isocitrate lyase from Pseudomonas aeruginosa are in- volved in its catalytic and thermal properties [J]. World J Microbiol Biotechnol, 2013, 29(6): 991-999.
  • 3KNAUS W A,DRAPER E A,WANGER D P,et al. APACHE II : a severity of classification system [ J ]. Criti Care Med, 1985,13 (40) :818-829.
  • 4GALLAGHER J C, ROUSE H M. Tigecycline for the treatment of Acinetobacter infections : a case series [ J ]. Ann Pharmacother, 2008,42(8) :1188-1194.
  • 5HEIZMANN W R,LOSCHMANN P A,ECKMANN C,et al. Clin- ical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria[ J]. Infection,2015,43 ( 11 ) :37-43.
  • 6DE PASCALE G,MONTINI L,PENNISI M,et al. High dose tige- cycline in critically ill patients with severe infection due to multi- drug-resistant bacteria[ J ]. Crit Care,2014,18 ( 3 ) : Rg0.
  • 7宋飞,金正江,付春花,胡玉莲.新生儿鲍曼不动杆菌感染状况及耐药性监测[J].实用儿科临床杂志,2009,24(4):313-314. 被引量:8
  • 8杨培,马春华,罗华.胆道感染患者的病原菌分布及耐药性分析[J].中华医院感染学杂志,2012,22(1):195-197. 被引量:8
  • 9陈佰义,何礼贤,胡必杰,倪语星,邱海波,石岩,施毅,王辉,王明贵,杨毅,张菁,俞云松.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志,2012,92(2):76-85. 被引量:848
  • 10习慧明,徐英春,朱德妹,汪复,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳,俞云松,杨青.2010年中国CHINET鲍曼不动杆菌耐药性监测[J].中国感染与化疗杂志,2012,12(2):98-104. 被引量:212

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部